Real-World data reveals how nivolumab performs in advanced lung cancer patients
NCT ID NCT04500535
First seen Dec 12, 2025 · Last updated May 21, 2026 · Updated 21 times
Summary
This study followed 535 people in France with advanced non-small cell lung cancer who were already prescribed nivolumab after at least one round of chemotherapy. Researchers observed how long treatment worked, side effects, and patients' quality of life. The goal was to learn more about real-world effectiveness and safety, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Local Institution - 0001
Paris, 75248, France
Conditions
Explore the condition pages connected to this study.